GL1X · GenesisL1 explorer

MolNFT v1 · #106313 · protein

Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL0519

4RVI: “Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic…”. X-ray diffraction, 1 ligand (G52), 3 pockets (best druggability 0.71). MolNFT v1 #106313 on GenesisL1: 3D structure…

PDB
4RVI
Type
protein
Length
396 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 protease
UniProt
Q9J006
Ligands
G52
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DHIV-1 proteaseprotein997% helix, 55% strandQ9J006

Ligands and binding sites

  • G52 · (3r,3as,3br,6as,7as)-octahydrodifuro[2,3-B:3',2'-d]furan-3-yl [(1S,2R)-1-benzyl-2-hydroxy-3-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl) amino}propyl]carbamate · ligand · 2 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14200.710.8242G52
24030.710.8241G52
3560.290.7511empty

Interfaces

3 interfaces between chains.

  • C–D · 1878 Ų buried · 39 hydrogen bonds · protein-protein
  • A–B · 1860 Ų buried · 37 hydrogen bonds · protein-protein
  • A–D · 131 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 4RVI · Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.